Inflammatory CNS diseases | | | |
Encephalitis | 2 (4.3%) | 8 (22.2%) | 0.018 |
Meningitis | 1 (2.1%) | 0 | 1.0 |
Multiple sclerosis | 1 (2.1%) | 3 (8.3%) | 0.31 |
Cerebral toxoplasmosis | 1 (2.1%) | 0 | 1.0 |
Cerebrovascular CNS diseases | | | |
Acute stroke | 0 | 3 (8.3%) | 0.78 |
Remote stroke | 7 (14.9%) | 4 (11.1%) | 0.75 |
Intracerebral haemorrhage | 2 (4.3%) | 2 (5.5%) | 1.0 |
Sinus venous thrombosis | 0 | 2 (5.5%) | 0.19 |
Secondary brain damage | | | |
Infantile brain damage | 1 (2.1%) | 1 (2.8%) | 1.0 |
Hypoxic brain damage | 0 | 3 (8.3%) | 0.78 |
Trauma | | | |
Post-traumatic brain damage | 2 (4.3%) | 0 | 0.5 |
Neoplasia | | | |
Primary brain tumour | 2 (4.3%) | 1 (2.8%) | 1.0 |
Cerebral metastasis | 3 (6.4%) | 2 (5.5%) | 1.0 |
Cortical developmental malformation | | | |
Cortical dysplasia | 0 | 1 (2.8%) | 0.43 |
Encephalopathy | | | |
Encephalopathy in hyperammonaemia | 0 | 1 (2.8%) | 0.43 |
Hypertensive encephalopathy | 1 (2.1%) | 1 (2.8%) | 1.0 |
Substance associated | | | |
Low levels of AEDs | 13 (27.7%) | 0 | <0.001 |
Alcohol-associated | 3 (6.4%) | 3 (8.3%) | 1.0 |
Drug associated | 1 (2.1%) | 1 (2.8%) | 1.0 |
Unknown | 7 (14.9%) | 0 (0%) | 0.017 |